Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the precision diagnostics market grown in recent years?

The scale of the precision diagnostics market has rapidly expanded in the past few years. It is projected to escalate from $98.14 billion in 2024 to $111.16 billion in 2025, reflecting a compound annual growth rate (CAGR) of 13.3%. The surge during the historical period can be ascribed to advancements in genomic research, the emergence of personalized medicine, the climbing incidence of chronic diseases, enhanced patient autonomy and informed choices, the shift in healthcare systems towards value-based care, and government incentives and funding.

How is the precision diagnostics market size expected to evolve during the forecast period?

The market size for precision diagnostics is projected to witness a robust expansion in the coming years, reaching a value of $192.06 billion by 2029 with a compound annual growth rate (CAGR) of 14.7%. This growth over the forecast period can be associated with the broader application of liquid biopsies, the incorporation of artificial intelligence (AI), increasing demand for companion diagnostics, the growth of point-of-care testing, and initiatives in population health management. During the prediction period, key trends include the technological advancements in sequencing, improvements in multi-omics technologies, the emergence of digital pathology, the integration of real-world evidence, and research and development collaborations.

Get your precision diagnostics market report here!

https://www.thebusinessresearchcompany.com/report/precision-diagnostics-global-market-report

Which key drivers are propelling the precision diagnostics market’s growth?

The growing occurrence of long-term illnesses is anticipated to drive the expansion of the precision diagnostics market. Chronic illnesses are those that persist for three months or more and may worsen over time. Precision diagnostics assists patients with chronic conditions such as cancer and cardiovascular diseases by precisely managing their healthcare model and providing accurate diagnosis. For example, the National Library of Medicine, a U.S. agency, projected in January 2023 that the population of individuals aged 50 and older in the U.S. with at least one chronic condition would rise to 142.66 million by 2050. As a result, the escalating occurrence of chronic illnesses is fueling the precision diagnostics market’s growth.

What are the market segments in the precision diagnostics industry?

The precision diagnostics market covered in this report is segmented –

1) By Type: Genetic Tests, Esoteric tests, Other Types

2) By Technology: Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), In Situ Hybridization (ISH), Mass Spectrometry, Immunohistochemistry (IHC), Other Technologies

3) By Application: Oncology, Infectious Diseases, Cardiovascular, Neurology, Genetic Disorders, Other Applications

4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By Genetic Tests: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR) Tests, Whole Exome Sequencing (WES), Single Nucleotide Polymorphism (SNP) Testing

2) By Esoteric Tests: Proteomics, Metabolomics, Specialized Infectious Disease Testing, Rare Disease Testing

3) By Other Types: Biomarker Testing, Liquid Biopsies, Companion Diagnostics, Pharmacogenomic Testing

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12025&type=smp

Which leading companies are shaping the growth of the precision diagnostics market?

Major companies operating in the precision diagnostics market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, Abbott Laboratories, Danaher Corporation, Amgen Inc., Koninklijke Philips N.V., Becton Dickinson and Company (BD), Thermo Fisher Scientific Inc., Quest Diagnostics Inc., Siemens Healthineers AG, Agilent Technologies Inc., PerkinElmer Inc., Beckman Coulter Inc., Charles River Laboratories International Inc., Sysmex America Inc., Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen N.V., Bio-Techne Corporation, Illumina Inc., Lantheus Medical Imaging Inc., Luminex Corporation, BioFire Diagnostics LLC, Genomic Health Inc., Swiss Precision Diagnostics GmbH, Bluebird Bio Inc.

What key trends are currently impacting the precision diagnostics market’s development?

Major firms in the precision diagnostics market are pivoting towards innovative therapy concepts, including tools like AI-assisted video analysis to augment patient engagement and simplify complex medical data comprehension, enabling people to take greater control of their health. An AI-enabled video analysis tool leverages artificial intelligence to decipher video content, highlighting key components in intricate health reports, and thereby offering considerable insights for better comprehension and educated decision-making. For instance, Healthians, an Indian diagnostics entity, launched an unprecedented AI-guided video analysis tool in August 2024. This tool demystifies complex health data by focusing on vital health parameters and explaining their implications, efficiently navigating users through their health summaries. This groundbreaking feature affords users personalized insights within a span of 15-30 minutes, subsequent to a quick survey on the Healthians application, magnifying their potential to make conscious health-related decisions.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12025

Which geographic areas are influencing the growth of the precision diagnostics market?

North America was the largest region in the precision diagnostics market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Regenerative Medicine Global Market Opportunities And Strategies To 2031

https://www.thebusinessresearchcompany.com/report/regenerative-medicine-market

Polymer Biomaterial Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/polymer-biomaterial-global-market-report

Biotechnology Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/biotechnology-services-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: